Article Versions Notes

Nitzan K, Ellenbogen L, Bentulila Z, David D, Franko M, Break EP, Zoharetz M, Shamir A, Sarne Y, Doron R. An Ultra-Low Dose of ∆9-Tetrahydrocannabinol Alleviates Alzheimer’s Disease-Related Cognitive Impairments and Modulates TrkB Receptor Expression in a 5XFAD Mouse Model. International Journal of Molecular Sciences. 2022; 23(16):9449. https://doi.org/10.3390/ijms23169449

Nitzan, Keren, Leah Ellenbogen, Ziv Bentulila, Dekel David, Motty Franko, Emanuela P. Break, Michal Zoharetz, Alon Shamir, Yosef Sarne, and Ravid Doron. 2022. "An Ultra-Low Dose of ∆9-Tetrahydrocannabinol Alleviates Alzheimer’s Disease-Related Cognitive Impairments and Modulates TrkB Receptor Expression in a 5XFAD Mouse Model" International Journal of Molecular Sciences 23, no. 16: 9449. https://doi.org/10.3390/ijms23169449

Nitzan, K., Ellenbogen, L., Bentulila, Z., David, D., Franko, M., Break, E. P., Zoharetz, M., Shamir, A., Sarne, Y., & Doron, R. (2022). An Ultra-Low Dose of ∆9-Tetrahydrocannabinol Alleviates Alzheimer’s Disease-Related Cognitive Impairments and Modulates TrkB Receptor Expression in a 5XFAD Mouse Model. International Journal of Molecular Sciences, 23(16), 9449. https://doi.org/10.3390/ijms23169449